Synergistic anti-leukemic activity of imatinib in combination with a small molecule Grb2 SH2 domain binding antagonist.

ABSTRACT:

SUBMITTER: Zhang M 

PROVIDER: S-EPMC3981872 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature